"Ann Intern Med"[journal] 检索结果

4501. Annals for Educators - 5 November 2019.

作者: Darren B Taichman.
来源: Ann Intern Med. 2019年171卷9期ED9页

4502. Web Exclusive. Annals On Call - Shorter-Duration Antibiotics for Community-Acquired Pneumonia.

作者: Robert M Centor.;Brad Spellberg.
来源: Ann Intern Med. 2019年171卷9期OC1页

4503. Web Exclusive. Annals Graphic Medicine - Dr. Mom: Dinosaurs on Rounds.

作者: Grace E Farris.
来源: Ann Intern Med. 2019年171卷9期W48-W52页

4504. Type 2 Diabetes.

作者: Sandeep Vijan.
来源: Ann Intern Med. 2019年171卷9期ITC65-ITC80页

Type 2 diabetes is a prevalent illness that causes major vascular, renal, and neurologic complications. Prevention and treatment of diabetes and its complications are of paramount importance. Many new treatments have emerged over the past 5-10 years. Recent evidence shows that newer treatments may substantially reduce risk for cardiac and renal disease, suggesting that it may be necessary to change existing treatment paradigms. This review summarizes the evidence supporting diabetes prevention and treatment, focusing on aspects that are commonly in the purview of primary care physicians.

4505. Colorectal Cancer Screening in Average-Risk Adults.

来源: Ann Intern Med. 2019年171卷9期

4506. Reconciling Disparate Guidelines: The American College of Physicians Colorectal Cancer Screening Guidance Statement.

作者: Michael Pignone.
来源: Ann Intern Med. 2019年171卷9期671-672页

4507. The Narcissist.

作者: Jerome Cantor.
来源: Ann Intern Med. 2019年171卷9期674页

4508. Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults: A Guidance Statement From the American College of Physicians.

作者: Amir Qaseem.;Carolyn J Crandall.;Reem A Mustafa.;Lauri A Hicks.;Timothy J Wilt.; .;Mary Ann Forciea.;Nick Fitterman.;Carrie A Horwitch.;Devan Kansagara.;Michael Maroto.;Robert M McLean.;Jairo Roa.;Janice Tufte.
来源: Ann Intern Med. 2019年171卷9期643-654页

The purpose of this guidance statement is to guide clinicians on colorectal cancer screening in average-risk adults.

4509. How Did I Get Here? Career Choice in Medicine.

作者: Charlie Goldberg.
来源: Ann Intern Med. 2019年171卷9期673-674页

4510. Correction: Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus in Chronic Kidney Disease.

来源: Ann Intern Med. 2019年171卷9期684页

4511. Correction: Rethinking Opioid Dose Tapering, Prescription Opioid Dependence, and Indications for Buprenorphine.

来源: Ann Intern Med. 2019年171卷9期684页

4512. Physician Impairment and Rehabilitation.

作者: Philip J Candilis.;Lois Snyder Sulmasy.
来源: Ann Intern Med. 2019年171卷9期681-682页

4513. Physician Impairment and Rehabilitation.

作者: Nicholas D Lawson.;J Wesley Boyd.
来源: Ann Intern Med. 2019年171卷9期680-681页

4514. Peripherally Inserted Central Catheters in Patients With Advanced Chronic Kidney Disease.

作者: David Paje.;Scott A Flanders.;Steven J Bernstein.;Vineet Chopra.
来源: Ann Intern Med. 2019年171卷9期683-684页

4515. Peripherally Inserted Central Catheters in Patients With Advanced Chronic Kidney Disease.

作者: Edward L Goodman.
来源: Ann Intern Med. 2019年171卷9期683页

4516. Mandated Imaging Appropriate Use Criteria.

作者: Keith D Hentel.;Andrew Menard.;John Mongan.;Jeremy C Durack.;Ali S Raja.;Ramin Khorasani.
来源: Ann Intern Med. 2019年171卷9期682-683页

4517. Mandated Imaging Appropriate Use Criteria.

作者: David M Mitchell.
来源: Ann Intern Med. 2019年171卷9期682页

4518. Risk of Biologics and Glucocorticoids in Patients With Rheumatoid Arthritis Undergoing Arthroplasty.

作者: Michael D George.;Joshua F Baker.;Kevin Winthrop.;Jeffrey R Curtis.
来源: Ann Intern Med. 2019年171卷9期680页

4519. Risk of Biologics and Glucocorticoids in Patients With Rheumatoid Arthritis Undergoing Arthroplasty.

作者: Maarten Boers.
来源: Ann Intern Med. 2019年171卷9期679-680页

4520. Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics: A Prospective Cohort Study.

作者: Gianluca Ianiro.;Rita Murri.;Giusi Desirè Sciumè.;Michele Impagnatiello.;Luca Masucci.;Alexander C Ford.;Graham R Law.;Herbert Tilg.;Maurizio Sanguinetti.;Roberto Cauda.;Antonio Gasbarrini.;Massimo Fantoni.;Giovanni Cammarota.
来源: Ann Intern Med. 2019年171卷10期695-702页

Clostridioides difficile infection (CDI) is a risk factor for bloodstream infection (BSI). Fecal microbiota transplantation (FMT) is more effective than antibiotics in treating recurrent CDI, but its efficacy in preventing CDI-related BSI is uncertain.

结果排序

文献格式

出版时间

出版类型

出版语言